A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients

Clinical trial NCT00613652 · COMPLETED

Trial details

NCT number: NCT00613652
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Tumors Carcinoma

Start date: 2008-01-01
Primary completion: 2009-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.